Harvard Study Identifies Lithium Variations as Early Alzheimer’s Indicator

Alzheimer's disease affects hundreds of millions globally, causing progressive brain decline and dementia symptoms. A Harvard Medical School study highlights the role of lithium as a natural brain mineral that maintains cell function, with decreased lithium levels linked to Alzheimer's, and dietary lithium showing promise in preventing the disease in mice. The MIND diet, emphasizing leafy greens, berries, nuts, and olive oil, is promoted for brain health and may reduce dementia risk at any age. New drugs targeting amyloid protein buildup, such as Kisunla, offer hope by potentially stabilizing memory and slowing disease progression, with growing patient programs across the country. A large brain imaging study reveals men experience slightly more brain aging than women, challenging assumptions about why Alzheimer's prevalence is higher in women. Advances in Alzheimer's clinical trials and drug development, including anti-amyloid therapies, indicate a transforming treatment landscape with promising new therapies and combination approaches emerging.